About OsciFlex

OsciFlex LLC was founded in 2017 by John Welsh, PhD and Mark Kahn, MD at the University of Pennsylvania. Dr. Welsh and Dr. Kahn discovered the molecular pathways relating blood flow pattern to endothelial gene expression of thrombosis related proteins, outlined a protocol to analyze venous valve oscillatory flow in human subjects using vascular ultrasound, and created the initial OsciFlex device design. 

Meet The Team

Mark-Kahn-MD-2.jpg

Mark Kahn,MD

Chief Medical Officer and Co-Founder

  • LinkedIn
John-Welsh-OsciFlex.jpg

John Welsh, PhD

CEO and Co-Founder

  • LinkedIn
IMG_5903.jpg

Mercedes Wesner

Product Development 

Lead

  • LinkedIn
IMG_4145.jpeg

Alex Santos

Product Development Lead

  • LinkedIn

Venous thromboembolism (VTE) prevention 

Post thrombotic syndrome (PTS) treatment

Improved vascular imaging

Core Values

Objectives

Funding Timeline

2017:

  • OsciFlex LLC founded by John Welsh, PhD & Mark Kahn, MD

2019:  

  • NSF SBIR PHASE I Grant

  • NIH STTR PHASE 1 Grant

  • Penn Cardiovascular Institute “Dream Team” Award

  • Penn Health Tech Award

  • Basic science publication accept to top journal (JCI 2019)

2021:

  • NIH SBIR PHASE II Grant

Core Values

2022:

  • NSF SBIR PHASE II Grant

Core Values